ATXA Publications & Posters


Conference Posters


NTP42, an antagonist of the thromboxane receptor, attenuates experimentally-induced pulmonary arterial hypertension

European Respiratory Society International Congress - Madrid, Spain - September/October 2019

Efficacy of the novel thromboxane receptor antagonist NTP42 alone, or in combination with Sildenafil, in the Sugen/hypoxia-induced model of pulmonary arterial hypertension

European Society of Cardiology World Congress - Paris, France - August/September 2019

© 2021 by ATXA Therapeutics Limited.

Dublin, Ireland

Home  |  About Us  |  News  |  Contact Us

Follow us on:

  • LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon